AngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Decreased by Trexquant Investment LP

Trexquant Investment LP lowered its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 70.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 81,771 shares of the medical instruments supplier's stock after selling 198,494 shares during the period. Trexquant Investment LP owned approximately 0.20% of AngioDynamics worth $749,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Geode Capital Management LLC raised its position in shares of AngioDynamics by 1.4% during the fourth quarter. Geode Capital Management LLC now owns 974,302 shares of the medical instruments supplier's stock worth $8,927,000 after purchasing an additional 13,535 shares during the period. StoneX Group Inc. purchased a new position in AngioDynamics in the 4th quarter worth about $981,000. Arrowstreet Capital Limited Partnership raised its holdings in AngioDynamics by 293.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 352,544 shares of the medical instruments supplier's stock worth $3,229,000 after buying an additional 263,034 shares during the period. Orion Portfolio Solutions LLC lifted its stake in AngioDynamics by 7.4% during the fourth quarter. Orion Portfolio Solutions LLC now owns 179,897 shares of the medical instruments supplier's stock valued at $1,648,000 after buying an additional 12,383 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of AngioDynamics by 46.0% in the fourth quarter. JPMorgan Chase & Co. now owns 807,483 shares of the medical instruments supplier's stock worth $7,397,000 after buying an additional 254,322 shares during the period. Institutional investors and hedge funds own 89.43% of the company's stock.

AngioDynamics Stock Down 0.1 %

Shares of AngioDynamics stock traded down $0.01 during midday trading on Thursday, hitting $9.45. The company's stock had a trading volume of 57,027 shares, compared to its average volume of 561,890. AngioDynamics, Inc. has a 1-year low of $5.47 and a 1-year high of $13.50. The firm has a market capitalization of $383.74 million, a P/E ratio of -1.67 and a beta of 0.52. The stock has a 50-day simple moving average of $9.72 and a 200-day simple moving average of $8.98.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last released its earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.16. The company had revenue of $72.00 million for the quarter, compared to analysts' expectations of $70.30 million. AngioDynamics had a negative return on equity of 7.26% and a negative net margin of 79.38%. The business's revenue for the quarter was down 4.3% on a year-over-year basis. As a group, sell-side analysts predict that AngioDynamics, Inc. will post -0.37 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, HC Wainwright restated a "buy" rating and set a $16.00 price target (up previously from $15.00) on shares of AngioDynamics in a report on Monday, April 7th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.